HermanRx vs BreezeMeds: Which GLP-1 Telehealth Fits You
Comparing HermanRx vs BreezeMeds: quick verdict first. HermanRx emphasizes genuinely all-inclusive monthly pricing for compounded semaglutide + B12 at $249/month and tirzepatide + B12 at $349/month with no membership or consultation fee, while BreezeMeds advertises lower starting prices for injectable semaglutide from $199 and tirzepatide from $299 but presents some pricing figures without clear product ties. Based on the supplied facts, choose HermanRx if you value explicit all-inclusive billing and a published 24 hour provider review plus 72 hour delivery timeline; choose BreezeMeds if you want lower starting price points to verify during intake.
Start HermanRx intake for all-inclusive GLP-1 pricing
Overview: pricing structure and transparency
HermanRx presents specific all-inclusive monthly prices: compounded semaglutide with B12 at $249/month and compounded tirzepatide with B12 at $349/month. Those prices are described as covering the provider review, prescription, medication, ongoing support and free discreet shipping with no membership fee and no separate consultation charge. BreezeMeds lists starting prices such as semaglutide injection from $199/month, tirzepatide injection from $299, and oral options from $399, but the source shows a separate $169 figure that is not clearly tied to a product and fees and billing commitments were not fully visible.
Key differences organized by evidence
1. Pricing clarity and what is included
HermanRx: explicit, labeled all-inclusive monthly prices and a clear statement that there is no membership or separate consultation fee. BreezeMeds: starting at prices are visible for multiple formulations, but the connection between every listed number and a specific product or billing commitment was not fully documented in the source.
Check BreezeMeds starting prices and offers
2. Product form and molecule availability
Both providers offer semaglutide and tirzepatide options. HermanRx explicitly lists compounded semaglutide + B12 and compounded tirzepatide + B12 as available for the stated all-inclusive prices. BreezeMeds displays injectable and oral semaglutide and tirzepatide options with starting prices for each form, including oral versions shown from $399.
3. Timeline and shipping
HermanRx publishes a roughly 5 minute assessment, provider review in about 24 hours, and delivery in about 72 hours if prescribed, and states free discreet shipping in plain unmarked packaging to all 50 states. BreezeMeds advertises discreet home delivery and ongoing support, but the source did not capture a detailed vendor timeline comparable to HermanRx.
4. Regulatory and compounding notices
Both sources note that treatment is available only when a licensed clinician determines it is medically appropriate. HermanRx states that compounded medications it offers are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. BreezeMeds indicates medication specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Comparison table at a glance
| Criteria | HermanRx | BreezeMeds |
|---|---|---|
| Semaglutide starting price | $249/mo compounded semaglutide + B12, all-inclusive | Semaglutide injection from $199/mo; oral from $399 |
| Tirzepatide starting price | $349/mo compounded tirzepatide + B12, all-inclusive | Tirzepatide injection from $299; oral from $399 |
| Pricing transparency | All-inclusive billing with no membership or consultation fee stated | Starting prices shown, some figures not clearly tied to products or billing |
| Shipping and timeline | Free discreet shipping to all 50 states; ~24h provider review, ~72h delivery | Discreet home delivery and ongoing support; timeline not fully documented |
| Regulatory note | Compounded medications not FDA approved; provider states both FDA approved and compounded options may be offered | Medication specific approval status must be confirmed; interchangeability not assumed |
Clinical access and platform scope
HermanRx is described as a U.S. telehealth platform matching patients with independent, licensed, board-certified physicians across five categories including weight loss and other specialties, and it highlights multi-category consolidation for patients who want to manage other treatments on one platform. BreezeMeds emphasizes an online intake, personalized treatment plan and discreet delivery, and its source recommends confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.
Begin HermanRx consultation for explicit all-in pricing
Risks, limits and what the source does not show
Both providers state treatment is available only when a licensed clinician determines it is medically appropriate. The source for HermanRx explicitly states that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. BreezeMeds notes that medication specific approval status must be confirmed. The source material does not supply independent outcome data, insurance acceptance details, or detailed renewal and cancellation terms for BreezeMeds; do not assume those details beyond what is provided.
Start BreezeMeds intake to confirm pricing and eligibility
Conclusion: choose based on what matters most
HermanRx vs BreezeMeds comes down to transparency and product presentation. Choose HermanRx if you want named all-inclusive monthly prices for compounded semaglutide + B12 at $249/month and compounded tirzepatide + B12 at $349/month, no membership or consultation fees, and a published quick review and shipping timeline. Choose BreezeMeds if you prioritize lower starting price points and want to confirm which specific product each price applies to during intake. The primary keyword HermanRx vs BreezeMeds summarizes that choice: HermanRx for clear all-in billing and timeline claims; BreezeMeds for advertised starting prices that require verification.
Choose HermanRx if you want explicit all-inclusive monthly pricing, published provider review and delivery timelines, and multi-category telehealth consolidation.